Effect of a Childcare Resource on Cervical Cancer Prevention

Status Recruiting

Clinical Trial Summary

Aim 1: Determine the prevalence of unmet childcare needs among women with abnormal cervical cancer screening and establish the relevance of childcare as a social determinant of health in the context of cervical dysplasia. Aim 2: Conduct a pilot pragmatic patient-randomized control trial (RCT) to evaluate the effectiveness of an intervention linking eligible patients to our childcare facility compared to standard of care on retention in care, defined as show-rate for the initial visit in the gynecology dysplasia clinic. The intervention will consist of 1) patient navigation to our childcare facility prior to the initial visit in the gynecology dysplasia clinic and 2) placement of an electronic medical record (EMR) referral to our childcare facility. Hypothesis: The study team hypothesizes that women receiving the intervention will have increased retention in care compared to women randomized to standard of care among women with abnormal cervical cancer screening referred to gynecology for diagnostic work-up. These two aims will demonstrate the significance of childcare as a social determinant of health in the cervical cancer screening and diagnostic continuum by assessing the burden of unmet childcare needs among women with cervical dysplasia and measuring the effect of health system-integrated childcare as an intervention for unmet childcare needs on retention in care and subsequent completion of diagnostic work-up among women with cervical dysplasia. This study will rigorously provide the first evidence illustrating the effect of health systems' investment in addressing unmet childcare needs on preventive care like cervical cancer screening. The findings of this proposed pilot study will be utilized to develop future large-scale studies with extramural funding, building a longitudinal program of research on addressing childcare as a social determinant of health in this and other similar clinical contexts (e.g., breast cancer screening and treatment).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06086054
Study type	Interventional
Source	University of Texas Southwestern Medical Center
Contact	Jillian Smartt, BSN
Phone	214-590-4049
Email	Jillian.Smartt@phhs.org
Status	Recruiting
Phase	N/A
Start date	October 31, 2023
Completion date	July 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04098744` - Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)	Phase 2
Recruiting	`NCT04226313` - Self-sampling for Non-attenders to Cervical Cancer Screening	N/A
Completed	`NCT01435590` - Endocervical Evaluation With the Curette Versus Cytobrush for the Diagnosis of Dysplasia of the Uterine Cervix	N/A
Completed	`NCT00212381` - Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia	Phase 3
Completed	`NCT05234112` - Prevention and Screening Towards Elimination of Cervical Cancer	N/A
Completed	`NCT04133610` - HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs	N/A
Not yet recruiting	`NCT04191603` - TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY	N/A
Active, not recruiting	`NCT02250716` - A Comparison of Immediate Treatment of CIN1 With Cryotherapy and 12 Month Cytology Follow up in HIV Seropositive Women	N/A
Recruiting	`NCT05640700` - Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
Completed	`NCT03502798` - Coherence Imaging of the Cervical Epithelium With Scanning a/LCI	N/A
Recruiting	`NCT06137950` - Interferon Alpha Therapy for Cervical CINI and HPV Infection	Phase 1
Withdrawn	`NCT01925378` - A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia	Phase 2
Completed	`NCT01766284` - Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix	N/A
Completed	`NCT01524003` - Chinese Cancer Prevention Study(CHICAPS)	N/A
Completed	`NCT04679675` - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial	N/A
Recruiting	`NCT04045652` - Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women
Completed	`NCT05756192` - Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening	N/A
Enrolling by invitation	`NCT04915495` - The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia	N/A
Completed	`NCT04751799` - Virtual Reality: Influence on Satisfaction, Pain, and Anxiety in Patients Undergoing Colposcopy	N/A
Recruiting	`NCT06054841` - Reshaping Postpartum Follow-up	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.